Renata Nobre da Fonseca , Mayara Fernanda Maggioli , Silvia de Oliveira Hübner , Fernando Vicosa Bauermann
{"title":"Antiviral effects of flavonoids on animal viruses","authors":"Renata Nobre da Fonseca , Mayara Fernanda Maggioli , Silvia de Oliveira Hübner , Fernando Vicosa Bauermann","doi":"10.1016/j.virol.2025.110596","DOIUrl":null,"url":null,"abstract":"<div><div>Flavonoids, plant-derived compounds widely recognized for their antioxidant, anti-inflammatory, and anticancer properties, also exhibit significant antiviral effects against various animal viruses. This review highlights the promising antiviral mechanisms of flavonoids, which include disrupting viral replication, blocking cell entry, and modulating immune responses. Notably, flavonoids like quercetin, kaempferol, and genistein have been shown to effectively inhibit viruses of veterinary importance, such as African Swine Fever Virus (ASFV), Porcine Epidemic Diarrhea Virus (PEDV), and Infectious Bronchitis Virus (IBV), among others. Although most studies demonstrate efficacy <em>in vitro</em>, the limited <em>in vivo</em> research underscores the need to further explore flavonoids’ antiviral potential in real-world applications. The immunomodulatory effects observed in some cases, where flavonoids regulate cytokine expression and reduce inflammation, suggest a dual action that could benefit both antiviral and anti-inflammatory responses. This body of research suggests that flavonoids could provide an option for managing animal viral infections. Yet, standardized methodologies and more <em>in vivo</em> studies are needed to validate these findings for veterinary use.</div></div>","PeriodicalId":23666,"journal":{"name":"Virology","volume":"610 ","pages":"Article 110596"},"PeriodicalIF":2.8000,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Virology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0042682225002090","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Flavonoids, plant-derived compounds widely recognized for their antioxidant, anti-inflammatory, and anticancer properties, also exhibit significant antiviral effects against various animal viruses. This review highlights the promising antiviral mechanisms of flavonoids, which include disrupting viral replication, blocking cell entry, and modulating immune responses. Notably, flavonoids like quercetin, kaempferol, and genistein have been shown to effectively inhibit viruses of veterinary importance, such as African Swine Fever Virus (ASFV), Porcine Epidemic Diarrhea Virus (PEDV), and Infectious Bronchitis Virus (IBV), among others. Although most studies demonstrate efficacy in vitro, the limited in vivo research underscores the need to further explore flavonoids’ antiviral potential in real-world applications. The immunomodulatory effects observed in some cases, where flavonoids regulate cytokine expression and reduce inflammation, suggest a dual action that could benefit both antiviral and anti-inflammatory responses. This body of research suggests that flavonoids could provide an option for managing animal viral infections. Yet, standardized methodologies and more in vivo studies are needed to validate these findings for veterinary use.
期刊介绍:
Launched in 1955, Virology is a broad and inclusive journal that welcomes submissions on all aspects of virology including plant, animal, microbial and human viruses. The journal publishes basic research as well as pre-clinical and clinical studies of vaccines, anti-viral drugs and their development, anti-viral therapies, and computational studies of virus infections. Any submission that is of broad interest to the community of virologists/vaccinologists and reporting scientifically accurate and valuable research will be considered for publication, including negative findings and multidisciplinary work.Virology is open to reviews, research manuscripts, short communication, registered reports as well as follow-up manuscripts.